Skip to main content
Professor Samuele Cortese

Professor Samuele Cortese

 M.D., Ph.D.
NIHR Research Professor

Research interests

  • Professor Cortese’s main research interests are around neurodevelopmental disorders, with a focus on ADHD, and sleep disorders. In his research, he uses advanced evidence synthesis methods, large datasets and RCTs to inform decision-making in clinical practice.

More research

Connect with Samuele

About

Samuele Cortese, MD, PhD is currently Full Professor of Child and Adolescent Psychiatry at the University of Southampton and Honorary Consultant Child and Adolescent Psychiatrist for Solent NHS Trust. He is also Adjunct Full Professor with the New York University (NYU).

His research focuses on neurodevelopmental disorders, in particular ADHD.

He is the Chair of the European ADHD Guidelines Group.

As of March 2023, he has published more than 300 peer-reviewed papers

In 2022, Prof. Cortese was included in the list of the world's most influential researchers of the past decade, ranking in the top 1% by citations in the field of psychiatry/psychology in 2021 in Web of Science

In 2022, he ranked  #1 worldwide in terms of expertise on Attention-Deficit/Hyperactivity Disorder (ADHD) according to Expertscape.

 

Summary of active grants

Agency, title

Period

Total Direct Costs

Role

NIHR (PgfAR)

Digital Sleep Support for Children with Attention- Deficit/Hyperactivity Disorder (The DISCA study)

2022-2028

£2.280.000,00

Joint Lead

European Research Agency- HORIZON, Epigenetic-genetic-mental health cascade based personalised prevention of noncommunicable disease in adolescents diagnosed with autism (ETHEREAL)

2022-2027

£3.400.000,00

Co-I

NIHR

Comparing pharmacological and non-pharmacological interventions for adults with Attention-Deficit/Hyperactivity Disorder (ADHD): systematic review and network meta-analysis

 

2022-2024

£149.400,00

PI

NIHR (EME)

Effects of external Trigeminal Nerve Stimulation in ADHD and mechanisms of action

2021-2025

£1,911,504.82

Co-investigator

NIHR

ARC Wessex

2021-2025

 £ 749,843

Co-applicant

NIHR (HTA)

Stimulant Medication for ADHD and Tics – Understanding Response versus Non-stimulants (SATURN study): a randomised trial of the clinical and cost-effectiveness of methylphenidate versus guanfacine for ADHD in children and young people with a co-existing tic disorder

2021-2025

£ 1,628,868.50

Co-investigator

 

NIHR (PgfAR)

On-Line Parent Training for the Initial Management of ADHD referral (OPTIMA)- RP-PG-0618-20003

2020-2025

£1,957,977.00

Co-investigator

 

Faculty of environmental and life sciences, University of Southampton, Knowledge Exchange and Enterprise Fund

2022-23

£14,700

PI

 Southampton Enterprise Development Fund

2023

£ 10,000

PI